NovaBay Pharmaceuticals, Inc. (NBY)

NovaBay Pharmaceuticals Revenue

In the year 2024, NovaBay Pharmaceuticals had annual revenue of $9.78M, down -6.45%.

• Revenue (ttm): $9.78M
• Revenue Growth: -6.45%
• P/S Ratio: 0.75
• Revenue / Employee: $698,643
• Employees: 14
• Market Cap: 7.68M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.78M	-674.00K	-6.45%
Dec 31, 2023	10.46M	-3.95M	-27.42%
Dec 31, 2022	14.40M	4.20M	41.16%
Dec 31, 2021	10.20M	270.00K	2.72%
Dec 31, 2020	9.93M	3.34M	50.54%
Dec 31, 2019	6.60M	-5.91M	-47.24%
Dec 31, 2018	12.51M	-5.72M	-31.39%
Dec 31, 2017	18.23M	6.33M	53.23%
Dec 31, 2016	11.90M	7.52M	171.56%
Dec 31, 2015	4.38M	3.33M	315.65%
Dec 31, 2014	1.05M	-2.42M	-69.69%
Dec 31, 2013	3.48M	-3.38M	-49.28%
Dec 31, 2012	6.86M	-4.14M	-37.64%
Dec 31, 2011	10.99M	1.24M	12.70%
Dec 31, 2010	9.75M	-5.93M	-37.81%
Dec 31, 2009	15.68M	8.96M	133.32%
Dec 31, 2008	6.72M	809.00K	13.68%
Dec 31, 2007	5.91M	1.43M	31.96%
Jun 30, 2007	4.48M	1.47M	48.57%
Mar 31, 2007	3.02M	1.48M	96.74%
Dec 31, 2006	1.53M	-	-
Dec 31, 2005	-	-	-